Actinium Pharmaceuticals, Inc. (ATNM) vs NanoViricides, Inc. (NNVC)

Actinium Pharmaceuticals, Inc. and NanoViricides, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and NanoViricides, Inc. are of similar size ($38.0M and $37.4M). NanoViricides, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.3×. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs −86.0%). Across the 13 metrics below, Actinium Pharmaceuticals, Inc. leads on 10 and NanoViricides, Inc. on 3.

Valuation

Metric ATNM NNVC Biotechnology median
P/E 3.33 n/m 7.88
P/S 1.07 n/m 11.47
P/B 1.24 3.40 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.17 n/m 0.74
EV/Sales 0.05 n/m 10.73
Earnings yield 30.00% (29.86%) (28.84%)
Free cash flow yield (61.70%) (23.69%) (23.03%)

Profitability

Metric ATNM NNVC Biotechnology median
Gross margin 98.71% 0.00% 65.16%
Operating margin 27.20% 0.00% 0.00%
Net margin 32.18% 0.00% 0.00%
Free cash flow margin (66.16%) 0.00% 0.00%
Return on equity 45.86% (89.97%) (57.72%)
Return on assets 21.92% (79.91%) (49.22%)
Return on invested capital 0.00% (86.02%) 0.00%

Growth

Metric ATNM NNVC Biotechnology median
Revenue growth (TTM) 2,731.18% — 5.64%
EPS growth (last fiscal year) 14.17% 10.00% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATNM NNVC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.08 3.17 4.73
Net debt to EBITDA 1.35 0.18 0.96

Dividend

Metric ATNM NNVC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATNM NNVC Biotechnology median
Market cap 37.42m 38.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack